William L. Holland
Analog Devices (United States)(US)University of Utah(US)Integra (United States)(US)Sheffield Teaching Hospitals NHS Foundation Trust(GB)
Publications by Year
Research Areas
Metabolism, Diabetes, and Cancer, Sphingolipid Metabolism and Signaling, Adipose Tissue and Metabolism, Cancer Risks and Factors, Pancreatic function and diabetes
Most-Cited Works
- → Inhibition of Ceramide Synthesis Ameliorates Glucocorticoid-, Saturated-Fat-, and Obesity-Induced Insulin Resistance(2007)1,201 cited
- → Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin(2010)872 cited
- → The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes(2013)870 cited
- → Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid–induced ceramide biosynthesis in mice(2011)678 cited
- → Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism(2008)567 cited
- → An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice(2013)522 cited